(Q36417179)

14 August 2017

Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression (English)

1 reference

14 August 2017

1 reference

1 reference

8

Carlos A Zarate

1 reference

14 August 2017

3

Nancy Brutsche

1 reference

14 August 2017

1

David A Luckenbaugh

1 reference

14 August 2017

2

Lobna Ibrahim

1 reference

14 August 2017

4

Jose Franco-Chaves

1 reference

14 August 2017

6

Craig A Marquardt

1 reference

14 August 2017

5

Daniel Mathews

1 reference

14 August 2017

Christy Cassarly

7

1 reference

14 August 2017

14 September 2012

1 reference

14 August 2017

1 reference

14 August 2017

14

1 reference

14 August 2017

8

1 reference

14 August 2017

880-887

1 reference

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Glutamatergic modulators: the future of treating mood disorders?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Glutamate plasticity in the drunken amygdala: the making of an anxious synapse.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Acamprosate: recent findings and future research directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

A rating scale for depression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Impact of substance abuse on the course and treatment of bipolar disorder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Bipolar affective disorder and substance abuse

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504126

Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats

30 September 2017

1 reference

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients

21 January 2018

1 reference

Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date

21 January 2018

1 reference

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

21 January 2018

1 reference

21 January 2018

1 reference

Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior

21 January 2018

1 reference

Reduced sensitivity to ketamine and pentobarbital in mice lacking the N-methyl-D-aspartate receptor GluRepsilon1 subunit

21 January 2018

1 reference

Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism

21 January 2018

1 reference

Mortality in patients with primary unipolar depression, secondary unipolar depression, and bipolar affective disorder: a comparison with general population mortality

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22978511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

From the Alcohol, Drug Abuse, and Mental Health Administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22978511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22978511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/BDI.12003

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3504126